Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: implications for therapy.
暂无分享,去创建一个
R. Versteeg | K. Pajtler | L. Klein-Hitpass | J. Koster | R. Schüle | R. Buettner | J. Schulte | I. Ora | A. Eggert | N. Friedrichs | A. Schramm | E. Metzger | Soyoung Lim | S. Kuhfittig-Kulle | J. Kirfel
[1] Birgit Samans,et al. MYCN regulates oncogenic MicroRNAs in neuroblastoma , 2007, International journal of cancer.
[2] O. Delattre,et al. Chromosomal CGH identifies patients with a higher risk of relapse in neuroblastoma without MYCN amplification , 2007, British Journal of Cancer.
[3] M. Machius,et al. Structural basis for the inhibition of the LSD1 histone demethylase by the antidepressant trans-2-phenylcyclopropylamine. , 2007, Biochemistry.
[4] A. Hoelz,et al. Lysine-specific demethylase 1 as a potential therapeutic target , 2007, Expert opinion on therapeutic targets.
[5] S. Baylin,et al. Inhibition of lysine-specific demethylase 1 by polyamine analogues results in reexpression of aberrantly silenced genes , 2007, Proceedings of the National Academy of Sciences.
[6] Gratien G. Prefontaine,et al. Opposing LSD1 complexes function in developmental gene activation and repression programmes , 2007, Nature.
[7] Roland Eils,et al. Translating Expression Profiling into a Clinically Feasible Test to Predict Neuroblastoma Outcome , 2007, Clinical Cancer Research.
[8] T. Jenuwein,et al. Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression , 2007, Nature Cell Biology.
[9] B. Lakowski,et al. CoREST-like complexes regulate chromatin modification and neuronal gene expression , 2007, Journal of Molecular Neuroscience.
[10] S. Halpain,et al. A microtubule-based, dynein-dependent force induces local cell protrusions: Implications for neurite initiation , 2007, Brain cell biology.
[11] R. Schüle,et al. Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence. , 2006, Cancer research.
[12] S. Steinberg,et al. Increased WSB1 copy number correlates with its over‐expression which associates with increased survival in neuroblastoma , 2006, Genes, chromosomes & cancer.
[13] Min Gyu Lee,et al. Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications. , 2006, Chemistry & biology.
[14] P. Cole,et al. A mechanism-based inactivator for histone demethylase LSD1. , 2006, Journal of the American Chemical Society.
[15] P. Houghton,et al. Potentiation of neuroblastoma metastasis by loss of caspase-8 , 2006, Nature.
[16] E. Connolly,et al. Chromosome 1p and 11q Deletions and Outcome in Neuroblastoma. , 2006, Neurosurgery.
[17] F. Lan,et al. Regulation of LSD1 histone demethylase activity by its associated factors. , 2005, Molecular cell.
[18] Min Gyu Lee,et al. An essential role for CoREST in nucleosomal histone 3 lysine 4 demethylation , 2005, Nature.
[19] Antoine H. F. M. Peters,et al. LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription , 2005, Nature.
[20] Peter Gunning,et al. Specific features of neuronal size and shape are regulated by tropomyosin isoforms. , 2005, Molecular biology of the cell.
[21] C. Leutner,et al. Acquired resistance to imatinib in gastrointestinal stromal tumours caused by multiple KIT mutations. , 2005, The Lancet. Oncology.
[22] Michael Baudis,et al. Unequivocal delineation of clinicogenetic subgroups and development of a new model for improved outcome prediction in neuroblastoma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] Roland Eils,et al. Microarray analysis reveals differential gene expression patterns and regulation of single target genes contributing to the opposing phenotype of TrkA- and TrkB-expressing neuroblastomas , 2005, Oncogene.
[24] M. Baiula,et al. Expression of the repressor element‐1 silencing transcription factor (REST) is influenced by insulin‐like growth factor‐I in differentiating human neuroblastoma cells , 2005, The European journal of neuroscience.
[25] Yang Shi,et al. Histone Demethylation Mediated by the Nuclear Amine Oxidase Homolog LSD1 , 2004, Cell.
[26] A. V. van Kuilenburg,et al. The novel histone deacetylase inhibitor BL1521 inhibits proliferation and induces apoptosis in neuroblastoma cells. , 2004, Biochemical pharmacology.
[27] G. Brodeur. Neuroblastoma: biological insights into a clinical enigma , 2003, Nature Reviews Cancer.
[28] F. Speleman,et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes , 2002, Genome Biology.
[29] R. Vallee,et al. Dynamin Isoform-specific Interaction with the Shank/ProSAP Scaffolding Proteins of the Postsynaptic Density and Actin Cytoskeleton* , 2001, The Journal of Biological Chemistry.
[30] Peter A. Jones,et al. The Role of DNA Methylation in Mammalian Epigenetics , 2001, Science.
[31] N. Sidell,et al. Retinoic acid-induced growth inhibition and morphologic differentiation of human neuroblastoma cells in vitro. , 1982, Journal of the National Cancer Institute.